STAM
gene geneOn this page
Also known as STAM1
Summary
STAM (signal transducing adaptor molecule, HGNC:11357) is a protein-coding gene on chromosome 10p12.33, encoding Signal transducing adapter molecule 1 (Q92783). Involved in intracellular signal transduction mediated by cytokines and growth factors.
This gene encodes a member of the signal-transducing adaptor molecule family. These proteins mediate downstream signaling of cytokine receptors and also play a role in ER to Golgi trafficking by interacting with the coat protein II complex. The encoded protein also associates with hepatocyte growth factor-regulated substrate to form the endosomal sorting complex required for transport-0 (ESCRT-0), which sorts ubiquitinated membrane proteins to the ESCRT-1 complex for lysosomal degradation. Alternatively spliced transcript variants have been observed for this gene.
Source: NCBI Gene 8027 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 94 total
- MANE Select transcript:
NM_003473
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11357 |
| Approved symbol | STAM |
| Name | signal transducing adaptor molecule |
| Location | 10p12.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | STAM1 |
| Ensembl gene | ENSG00000136738 |
| Ensembl biotype | protein_coding |
| OMIM | 601899 |
| Entrez | 8027 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000377500, ENST00000377524, ENST00000445846, ENST00000486183, ENST00000494250, ENST00000892729, ENST00000892730, ENST00000925944, ENST00000945545
RefSeq mRNA: 9 — MANE Select: NM_003473
NM_001324282, NM_001324283, NM_001324284, NM_001324285, NM_001324286, NM_001324287, NM_001324288, NM_001324289, NM_003473
CCDS: CCDS7122
Canonical transcript exons
ENST00000377524 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001826722 | 17714543 | 17716824 |
| ENSE00002466179 | 17704970 | 17705024 |
| ENSE00002468964 | 17708776 | 17708951 |
| ENSE00002470459 | 17700191 | 17700279 |
| ENSE00002476979 | 17705588 | 17705741 |
| ENSE00002489468 | 17704431 | 17704518 |
| ENSE00002513600 | 17693222 | 17693312 |
| ENSE00002719358 | 17644151 | 17644379 |
| ENSE00003394798 | 17695049 | 17695241 |
| ENSE00003497319 | 17684832 | 17684927 |
| ENSE00003578247 | 17660464 | 17660548 |
| ENSE00003604926 | 17688027 | 17688173 |
| ENSE00003624138 | 17696775 | 17696869 |
| ENSE00003644505 | 17684675 | 17684750 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 94.01.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.5463 / max 673.6114, expressed in 1823 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104094 | 19.7182 | 1815 |
| 104096 | 12.9859 | 1767 |
| 104095 | 4.6593 | 1603 |
| 104098 | 1.6375 | 453 |
| 104093 | 0.5454 | 305 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 94.01 | gold quality |
| amniotic fluid | UBERON:0000173 | 91.59 | gold quality |
| endothelial cell | CL:0000115 | 91.58 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.83 | gold quality |
| corpus callosum | UBERON:0002336 | 90.59 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 90.27 | gold quality |
| cortical plate | UBERON:0005343 | 89.88 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 89.63 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 89.63 | gold quality |
| pons | UBERON:0000988 | 89.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.55 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 89.38 | gold quality |
| gingival epithelium | UBERON:0001949 | 89.35 | gold quality |
| cerebellar vermis | UBERON:0004720 | 89.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.16 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 88.98 | gold quality |
| postcentral gyrus | UBERON:0002581 | 88.92 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 88.62 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.59 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 88.52 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 88.47 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 88.46 | gold quality |
| bone marrow | UBERON:0002371 | 88.41 | gold quality |
| parietal lobe | UBERON:0001872 | 88.39 | gold quality |
| adrenal tissue | UBERON:0018303 | 88.29 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 88.25 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 88.16 | gold quality |
| stromal cell of endometrium | CL:0002255 | 88.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.83 | gold quality |
| tendon | UBERON:0000043 | 87.59 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-120 | yes | 49.33 |
| E-ANND-3 | yes | 9.10 |
| E-MTAB-7249 | no | 251.72 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1, E2F4, ZNF331
miRNA regulators (miRDB)
129 targeting STAM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
Literature-anchored findings (GeneRIF, showing 15)
- STAM proteins function in a multivalent complex that sorts ubiquitinated proteins into the multivesicular body pathway. (PMID:12551915)
- Interaction of TIMM8a with STAM1. (PMID:12745081)
- Data suggested that association with hepatocyte growth factor-regulated tyrosine kinase substrate is a prerequisite for STAM1 function in early endosome. (PMID:15113837)
- Hrs is a master molecule that controls in part the degradation of STAM1 and the accumulation of ubiquitinated proteins (PMID:15640163)
- Analysis with phospho-specific antibodies indicates that 3 kinases generate a signal-specific, combinatorial phosphorylation profile of the Hrs-STAM complex, with the potential of diversifying tyrosine kinase receptor signalling through a common element. (PMID:15828871)
- The cellular functions of UBPY are complex but clearly distinct from those of the Lys-63-ubiquitin-specific protease, AMSH, with which it shares a binding site on the SH3 domain of STAM (PMID:16520378)
- STAMs function prominently in endoplasmic reticulum-to-Golgi trafficking, most likely through direct interactions with the coat protein II complex (PMID:19054391)
- A novel ubiquitin binding site and the manner of ubiquitin recognition of the STAM1 VHS domain were proposed. (PMID:19111546)
- Overexpression of an AIP4 catalytically inactive mutant and a mutant that shows poor binding to STAM-1 fails to enhance CXCR4-induced ERK-1/2 signaling. (PMID:22275353)
- ESCRT-0 protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is targeted to endosomes independently of signal-transducing adaptor molecule (STAM) and the complex formation with STAM promotes its endosomal dissociation. (PMID:25296754)
- Differential expression of the transcripts STAM connects ubiquitin-proteasome system with infection-inflammation in preterm births and preterm premature rupture of membranes. (PMID:25884766)
- The VHS domain of STAM1 directs AMSH to cleave longer Lys63-linked ubiquitin chains (PMID:26601948)
- The beta-arrestin1.STAM1 complex is necessary for promoting autophosphorylation of focal adhesion kinase (FAK). FAK is necessary for CXCL12-induced chemotaxis and associates with and localizes with beta-arrestin1 and STAM1 in a CXCL12-dependent manner. (PMID:27789711)
- A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme. (PMID:32065482)
- A non-GPCR-binding partner interacts with a novel surface on beta-arrestin1 to mediate GPCR signaling. (PMID:32753481)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | stam | ENSDARG00000002127 |
| mus_musculus | Stam | ENSMUSG00000026718 |
| rattus_norvegicus | Stam | ENSRNOG00000060817 |
| drosophila_melanogaster | Stam | FBGN0027363 |
| drosophila_melanogaster | Gga | FBGN0030141 |
| drosophila_melanogaster | Wdfy2 | FBGN0032246 |
| caenorhabditis_elegans | stam-1 | WBGENE00004109 |
| caenorhabditis_elegans | WBGENE00008402 |
Paralogs (10): WDFY1 (ENSG00000085449), GGA1 (ENSG00000100083), TOM1 (ENSG00000100284), GGA2 (ENSG00000103365), STAM2 (ENSG00000115145), GGA3 (ENSG00000125447), WDFY2 (ENSG00000139668), TOM1L1 (ENSG00000141198), TOM1L2 (ENSG00000175662), HGS (ENSG00000185359)
Protein
Protein identifiers
Signal transducing adapter molecule 1 — Q92783 (reviewed: Q92783)
All UniProt accessions (3): A6NMU3, C9J1E5, Q92783
UniProt curated annotations — full annotation on UniProt →
Function. Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as a sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes. (Microbial infection) Plays an important role in Dengue virus entry.
Subunit / interactions. Component of the ESCRT-0 complex composed of STAM or STAM2 and HGS. Probably part of a complex at least composed of HSG, STAM and EPS15. Found in a complex with HGS and E3 ligase ITCH and DTX3L. Interacts with E3 ligase DTX3L; the interaction brings together STAM and HSG, promotes their recruitment to early endosomes and decreases STAM and HGS ubiquitination by ITCH. Interacts with STAMBP/AMSH. Interacts with PDGFRB. Interacts with LITAF; the interaction is direct. Identified in a complex with HGS and LITAF. Interacts with HAVCR1.
Subcellular location. Cytoplasm. Early endosome membrane.
Tissue specificity. Ubiquitously expressed.
Post-translational modifications. Phosphorylated on Tyr-198. Phosphorylated in response to IL2, IL3, IL4, IL7, CSF2/GM-CSF, EGF and PDGFB. Phosphorylated by activated PDGFRB. Ubiquitinated by ITCH.
Domain organisation. The VHS domain mediates high-avidity binding to Lys63-linked and Lys48-linked polyubiquitinated cargos.
Similarity. Belongs to the STAM family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q92783-1 | 1 | yes |
| Q92783-2 | 2 |
RefSeq proteins (9): NP_001311211, NP_001311212, NP_001311213, NP_001311214, NP_001311215, NP_001311216, NP_001311217, NP_001311218, NP_003464* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001452 | SH3_domain | Domain |
| IPR002014 | VHS_dom | Domain |
| IPR003903 | UIM_dom | Conserved_site |
| IPR008942 | ENTH_VHS | Homologous_superfamily |
| IPR035657 | STAM1_SH3 | Domain |
| IPR036028 | SH3-like_dom_sf | Homologous_superfamily |
| IPR047492 | GAT_STAM1 | Domain |
| IPR047528 | VHS_STAM1 | Domain |
| IPR050670 | STAM | Family |
Pfam: PF00018, PF00790, PF02809
UniProt features (35 total): helix 11, strand 6, modified residue 4, domain 4, splice variant 2, compositionally biased region 2, initiator methionine 1, chain 1, cross-link 1, sequence variant 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3F1I | X-RAY DIFFRACTION | 2.3 |
| 3LDZ | X-RAY DIFFRACTION | 2.6 |
| 2L0A | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q92783-F1 | 68.54 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 198, 381, 384, 276, 156
Function
Pathways and Gene Ontology
Reactome pathways
24 pathways
| ID | Pathway |
|---|---|
| R-HSA-182971 | EGFR downregulation |
| R-HSA-5689901 | Metalloprotease DUBs |
| R-HSA-6807004 | Negative regulation of MET activity |
| R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| R-HSA-8856828 | Clathrin-mediated endocytosis |
| R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell |
| R-HSA-9013420 | RHOU GTPase cycle |
| R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) |
| R-HSA-162582 | Signal Transduction |
| R-HSA-1643685 | Disease |
| R-HSA-177929 | Signaling by EGFR |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-5663205 | Infectious disease |
| R-HSA-5688426 | Deubiquitination |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-6806834 | Signaling by MET |
| R-HSA-8876384 | Listeria monocytogenes entry into host cells |
| R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
| R-HSA-9012999 | RHO GTPase cycle |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
| R-HSA-9824439 | Bacterial Infection Pathways |
MSigDB gene sets: 285 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, AHRARNT_01, REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT, GOBP_ENDOSOME_ORGANIZATION, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_VESICLE_LOCALIZATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_ORGANIZATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_REGULATION_OF_EXOCYTOSIS, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS
GO Biological Process (8): signal transduction (GO:0007165), macroautophagy (GO:0016236), multivesicular body assembly (GO:0036258), protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328), membrane fission (GO:0090148), positive regulation of exosomal secretion (GO:1903543), regulation of extracellular exosome assembly (GO:1903551), protein transport (GO:0015031)
GO Molecular Function (4): phosphatidylinositol binding (GO:0035091), ubiquitin binding (GO:0043130), ubiquitin-like protein ligase binding (GO:0044389), protein binding (GO:0005515)
GO Cellular Component (6): cytosol (GO:0005829), early endosome membrane (GO:0031901), ESCRT-0 complex (GO:0033565), cytoplasm (GO:0005737), endosome (GO:0005768), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Membrane Trafficking | 2 |
| Signaling by Receptor Tyrosine Kinases | 2 |
| Signaling by EGFR | 1 |
| Deubiquitination | 1 |
| Signaling by MET | 1 |
| Clathrin-mediated endocytosis | 1 |
| Listeria monocytogenes entry into host cells | 1 |
| RHO GTPase cycle | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Vesicle-mediated transport | 1 |
| Disease | 1 |
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
| Bacterial Infection Pathways | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| autophagosome assembly | 1 |
| autophagy | 1 |
| multivesicular body organization | 1 |
| organelle assembly | 1 |
| intracellular protein transport | 1 |
| late endosome to vacuole transport via multivesicular body sorting pathway | 1 |
| ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1 |
| protein localization to vacuole | 1 |
| establishment of protein localization to vacuole | 1 |
| membrane organization | 1 |
| positive regulation of cellular component biogenesis | 1 |
| positive regulation of exocytosis | 1 |
| regulation of exosomal secretion | 1 |
| exosomal secretion | 1 |
| extracellular exosome assembly | 1 |
| regulation of organelle assembly | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| anion binding | 1 |
| ubiquitin-like protein binding | 1 |
| enzyme binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| early endosome | 1 |
| endosome membrane | 1 |
| ESCRT complex | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
Protein interactions and networks
STRING
1582 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STAM | HGS | O14964 | 992 |
| STAM | STAMBP | O95630 | 979 |
| STAM | TSG101 | Q99816 | 945 |
| STAM | JAK3 | P52333 | 818 |
| STAM | EPS15 | P42566 | 791 |
| STAM | VPS36 | Q86VN1 | 757 |
| STAM | STAM2 | O75886 | 747 |
| STAM | CHMP4A | Q9BY43 | 734 |
| STAM | USP8 | P40818 | 727 |
| STAM | VTA1 | Q9NP79 | 691 |
| STAM | VPS28 | Q9UK41 | 669 |
| STAM | STAP2 | Q9UGK3 | 669 |
| STAM | VPS25 | Q9BRG1 | 664 |
| STAM | CHMP6 | Q96FZ7 | 663 |
| STAM | JAK2 | O60674 | 649 |
IntAct
106 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HGS | STAM | psi-mi:“MI:0915”(physical association) | 0.860 |
| STAM | HGS | psi-mi:“MI:0914”(association) | 0.860 |
| STAM | HGS | psi-mi:“MI:0915”(physical association) | 0.860 |
| TSG101 | VPS37C | psi-mi:“MI:0914”(association) | 0.780 |
| STAM | STAMBP | psi-mi:“MI:0915”(physical association) | 0.770 |
| STAMBP | STAM | psi-mi:“MI:0407”(direct interaction) | 0.770 |
| STAM | STAMBP | psi-mi:“MI:0407”(direct interaction) | 0.770 |
| STAM | UBC | psi-mi:“MI:0407”(direct interaction) | 0.770 |
| UBC | STAM | psi-mi:“MI:0407”(direct interaction) | 0.770 |
| STAMBP | STAM | psi-mi:“MI:0915”(physical association) | 0.770 |
| YWHAB | BLTP3B | psi-mi:“MI:0914”(association) | 0.610 |
| HGS | STAM2 | psi-mi:“MI:0914”(association) | 0.550 |
| BAG2 | HGS | psi-mi:“MI:0914”(association) | 0.530 |
| LCP2 | STAM | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| STAM | LCP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| UBB | STAM | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| STAM | UBB | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (286): STAM (Protein-peptide), STAM (Reconstituted Complex), UBC (Protein-peptide), STAM (Biochemical Activity), HGS (Two-hybrid), GGA1 (Co-fractionation), STAM (Co-fractionation), STAM (Co-fractionation), STAM (Affinity Capture-MS), HGS (Affinity Capture-Western), STAM (Proximity Label-MS), STAM (Proximity Label-MS), STAM (Proximity Label-MS), UBC (Reconstituted Complex), STAM (Affinity Capture-Western)
ESM2 similar proteins: A1CEK1, A1CEK6, A1DFN5, A1DFP5, A2QW93, A2QWA2, A3LX75, A3LXQ8, A4QTV1, A4RF61, O01498, O14964, O43125, O88811, P0CR78, P0CR79, P0CS26, P0CS27, P38753, P70297, Q0CJU8, Q0CJV3, Q0U4Z8, Q0U6X7, Q0V8S0, Q1E878, Q2GS33, Q2GT05, Q4P5J4, Q4P7Q1, Q4WHN8, Q4WHP5, Q5A895, Q5BBK9, Q5BBL4, Q5XHY7, Q6BNP6, Q6BSD6, Q6C2N2, Q6CFT4
Diamond homologs: A0A0G2JV04, A3LXQ8, F4KAU9, O01498, O14964, O43747, O60784, O75843, O75886, O88512, O88746, O93436, P22892, P70297, Q0V8S0, Q5R5M2, Q68FJ8, Q6P5E6, Q8BMI3, Q8R0H9, Q92783, Q960X8, Q99LI8, Q9JJ50, Q9NZ52, Q9UJY4, Q9UJY5, A0JNJ1, A1CEK6, A1DFN5, A2QW93, A4RF61, A6QLK6, A7A261, F1LRS8, O35179, O35964, O43307, O74749, O75791
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| USP8 | “up-regulates quantity” | STAM | binding |
| STAM | “form complex” | “ESCRT-0 complex” | binding |
| JAK2 | up-regulates | STAM | phosphorylation |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 103 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Endosomal Sorting Complex Required For Transport (ESCRT) | 7 | 34.9× | 5e-07 |
| Late endosomal microautophagy | 7 | 30.9× | 6e-07 |
| Budding and maturation of HIV virion | 5 | 27.6× | 1e-04 |
| Attenuation phase | 5 | 27.6× | 1e-04 |
| HSF1-dependent transactivation | 5 | 21.4× | 3e-04 |
| Regulation of HSF1-mediated heat shock response | 6 | 11.3× | 8e-04 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 6 | 10.3× | 1e-03 |
| ER-Phagosome pathway | 5 | 8.8× | 6e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5 | 58.5× | 6e-06 |
| multivesicular body assembly | 6 | 35.1× | 6e-06 |
| peptidyl-tyrosine phosphorylation | 5 | 23.4× | 4e-04 |
| membrane fission | 5 | 22.8× | 4e-04 |
| macroautophagy | 6 | 16.1× | 4e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
94 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 2 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2159 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:17644376:GTTG:G | donor_gain | 1.0000 |
| 10:17644377:TTGG:T | donor_loss | 1.0000 |
| 10:17644379:GGT:G | donor_loss | 1.0000 |
| 10:17660453:A:AG | acceptor_gain | 1.0000 |
| 10:17660455:A:AG | acceptor_gain | 1.0000 |
| 10:17660545:CTGG:C | donor_gain | 1.0000 |
| 10:17660545:CTGGG:C | donor_loss | 1.0000 |
| 10:17660546:TGG:T | donor_gain | 1.0000 |
| 10:17660547:GG:G | donor_gain | 1.0000 |
| 10:17660547:GGG:G | donor_gain | 1.0000 |
| 10:17660548:GG:G | donor_gain | 1.0000 |
| 10:17660549:G:GA | donor_loss | 1.0000 |
| 10:17660549:G:GG | donor_gain | 1.0000 |
| 10:17660550:T:TC | donor_loss | 1.0000 |
| 10:17660551:AA:A | donor_loss | 1.0000 |
| 10:17684672:TAG:T | acceptor_loss | 1.0000 |
| 10:17684673:A:AG | acceptor_gain | 1.0000 |
| 10:17684674:G:GG | acceptor_gain | 1.0000 |
| 10:17684674:GACCT:G | acceptor_gain | 1.0000 |
| 10:17684747:GACT:G | donor_gain | 1.0000 |
| 10:17684749:CT:C | donor_gain | 1.0000 |
| 10:17684751:G:GG | donor_gain | 1.0000 |
| 10:17688021:TTACA:T | acceptor_loss | 1.0000 |
| 10:17688022:TACA:T | acceptor_loss | 1.0000 |
| 10:17688023:ACAG:A | acceptor_gain | 1.0000 |
| 10:17688024:CA:C | acceptor_loss | 1.0000 |
| 10:17688025:A:AG | acceptor_gain | 1.0000 |
| 10:17688025:AG:A | acceptor_gain | 1.0000 |
| 10:17688026:G:GC | acceptor_loss | 1.0000 |
| 10:17688026:G:GT | acceptor_gain | 1.0000 |
AlphaMissense
3575 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:17660499:T:A | W26R | 1.000 |
| 10:17660499:T:C | W26R | 1.000 |
| 10:17660501:G:C | W26C | 1.000 |
| 10:17660501:G:T | W26C | 1.000 |
| 10:17684689:T:C | L47P | 1.000 |
| 10:17684707:G:C | R53T | 1.000 |
| 10:17684708:A:C | R53S | 1.000 |
| 10:17684708:A:T | R53S | 1.000 |
| 10:17684727:C:G | H60D | 1.000 |
| 10:17684731:T:A | V61D | 1.000 |
| 10:17684734:C:A | A62D | 1.000 |
| 10:17684742:G:C | A65P | 1.000 |
| 10:17684743:C:A | A65D | 1.000 |
| 10:17684746:T:G | L66W | 1.000 |
| 10:17684833:T:A | L68H | 1.000 |
| 10:17684833:T:C | L68P | 1.000 |
| 10:17684836:T:C | L69P | 1.000 |
| 10:17684884:G:A | C85Y | 1.000 |
| 10:17684885:T:G | C85W | 1.000 |
| 10:17684886:T:C | S86P | 1.000 |
| 10:17684890:G:C | R87T | 1.000 |
| 10:17684890:G:T | R87I | 1.000 |
| 10:17684891:A:C | R87S | 1.000 |
| 10:17684891:A:T | R87S | 1.000 |
| 10:17688072:T:A | W115R | 1.000 |
| 10:17688072:T:C | W115R | 1.000 |
| 10:17688103:T:C | L125P | 1.000 |
| 10:17688109:T:C | L127P | 1.000 |
| 10:17688133:T:C | L135P | 1.000 |
| 10:17695052:T:A | I180N | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000012853 (10:17667088 A>G), RS1000172040 (10:17653010 G>T), RS1000185728 (10:17688332 A>G), RS1000203028 (10:17652760 G>A), RS1000361401 (10:17678505 C>G,T), RS1000366909 (10:17694361 G>A), RS1000385544 (10:17657346 T>G), RS1000492261 (10:17663308 T>A), RS1000521466 (10:17648041 A>G), RS1000570379 (10:17704945 A>G,T), RS1000580187 (10:17705245 A>G), RS1000619718 (10:17688622 C>G), RS1000758021 (10:17657586 C>T), RS1000772331 (10:17673979 G>A), RS1000878641 (10:17699973 T>C)
Disease associations
OMIM: gene MIM:601899 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, increases expression | 2 |
| cobaltous chloride | increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| FR900359 | affects phosphorylation | 1 |
| pyrogallol 1,3-dimethyl ether | affects cotreatment, affects localization, increases expression | 1 |
| salinomycin | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| AM 251 | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Carmustine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Furaldehyde | affects cotreatment, affects localization, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Sodium Chloride | affects cotreatment, affects localization, decreases expression, increases expression | 1 |
| Testosterone | increases expression | 1 |
| Thiram | increases expression | 1 |
Cellosaurus cell lines
5 cell lines: 3 cancer cell line, 2 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3ID | Abcam HEK293T STAM KO | Transformed cell line | Female |
| CVCL_D8BH | Ubigene A-549 STAM KO | Cancer cell line | Male |
| CVCL_D8WB | Ubigene HCT 116 STAM KO | Cancer cell line | Male |
| CVCL_D9T4 | Ubigene HEK293 STAM KO | Transformed cell line | Female |
| CVCL_E0Q0 | Ubigene HeLa STAM KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.